Uses Decongestants are used primarily in the treatment of hay fever, vasomotor rhinitis, and intrinsic rhinitis. They also provide some relief of allergy of the stomach and intestines (gastrointestinal allergy) and occasionally of hives. For treating hives, however, drugs such as epinephrine and ephedrine are used more widely. Representative Drugs Pseudoephedrine hydrochloride (D-Feda, Novafed, and Sudafed) are probably the most widely used oral decongestants. Others are ephedrine, phenylephrine, phenylpropanolamine (Propadrine), and pseudoephedrine sulfate (Afrinol). Ephedrine, which stimulates the central nervous system more than do such drugs as pseudoephedrine, is used primarily as a bronchodilator. Pseudoephedrine has fewer side effects than ephedrine. Although it is active as a bronchodilator, it is less effective than other drugs in treating asthma. Commonly used intranasal preparations are naphazoline (Privine), oxymetazoline (Afrin), phenylephrine (Neo-Synephrine), tetrahydrozoline (Ty-zine), and zymetazoline (Otrivin). Side Ettects and Precautions Among the side effects of oral preparations, as well as the effects of overdoses of intranasal preparations, are nervousness, dizziness, nausea, awareness of heartbeat (usually rapid), and occasionally stimulation of the central nervous system. Other effects, which usually occur among children, are high blood pressure, slow heart rate, ir regular heart rhythm, and low blood pressure. Children have also been known to experience severe side effects, including sweating, drowsiness, deep sleep, coma, hypotension, and slow heart rate. Because of the effects listed above, caution should be exercised when these drugs are used in people with heart disease, high blood pressure, sugar diabetes, thyroid disease, or any combination of these diseases, or those taking drugs (also known as "mood elevators") of the tricyclic class. Patients taking the monoamine oxidase (MAO) inhibitor class of antidepressive drugs should not also use decongestant drugs. Intranasal agents require additional precautions. For example, they should be used only in treating illnesses that are short and relatively severe, that is, illnesses that do not exceed five days in duration. Prolonged use often causes a "rebound" phenomenon in which, while more and more of the drug is required, the desired effect of the drug becomes increasingly less. More frequent and larger doses of a drug are used, accompanied by the twin risks of overdose and toxicity. Prolonged use causes rhinitis medicamentosum, a condition in which the mucous membranes of the nasal passages become red, boggy, or pale gray and edematous (swelling with fluid between the cells) and in which the inflamed membranes are indistinguishable from other forms of chronic inflammation of the nose, such as year-round hay fever (perennial allergic rhinitis). Topical nasal decongestant solutions quickly become contaminated with bacteria and fungi after use, and for this reason, may be sources of infection. Some rules to follow in using spray decongestants are: 1. Rinse the spray tip or dropper in hot water after each use. 2. Do not place the spray tip or dropper inside the nose. 3. Confine use of a particular applicator to one person. 4. Discard the medication and its container when the medication is no longer needed. Something over which people have no control, but which they should be aware of, is that most topical nasal decongestant solutions interact with aluminum and thus should not be stored in containers made wholly or in part of the metal. Bronchodilators Uses Bronchodilators are used primarily in treating asthma, but they are also used to treat chronic bronchitis and emphysema, diseases of the lung which chronically obstruct the air passages, as well as to treat bronchiectasis, in which dilatations occur in the air passages of the lungs. Some bronchodilators are useful in alleviating several forms of hives. Epinephrine was the first drug chosen for treating allergic or allergylike responses involving more than one body system, for example, the simultaneous occurrence of hives and asthma. Another bron-chodilator is aminophylline, which is useful as a supplemental treatment in some cases of systemic reaction. Representative Drugs Three classes of bronchodilators are currently being used: adrenergic agonists (also known as sympathomimetic drugs); methylxan-thines; and anticholinergics (also known as parasympatholytic drugs). Anticholinergic drugs are now being tested and have not yet been approved by the Food and Drug Administration. Other drugs now being tested are alpha adrenergic agonists and prostaglandins.